No abstract available
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Adenylyl Cyclases / metabolism
-
Adult
-
Alprostadil* / pharmacology
-
Alprostadil* / physiology
-
Alprostadil* / therapeutic use
-
Animals
-
Blood Platelets / drug effects
-
Blood Platelets / metabolism
-
Coronary Disease / drug therapy
-
Double-Blind Method
-
Drug Evaluation
-
Drug Tolerance
-
Ductus Arteriosus / drug effects
-
Enzyme Activation / drug effects
-
Epoprostenol* / pharmacology
-
Epoprostenol* / physiology
-
Epoprostenol* / therapeutic use
-
Extracorporeal Circulation / adverse effects
-
Heart Defects, Congenital / drug therapy
-
Heart Failure / drug therapy
-
Humans
-
Hypertension, Pulmonary / drug therapy
-
Infant
-
Infant, Newborn
-
Platelet Aggregation / drug effects
-
Raynaud Disease / drug therapy
-
Receptors, Epoprostenol
-
Receptors, Prostaglandin / metabolism
-
Receptors, Prostaglandin E
-
Renal Dialysis / adverse effects
-
Second Messenger Systems
-
Thrombocytopenia / etiology
-
Thrombocytopenia / prevention & control
-
Vascular Diseases / drug therapy
Substances
-
Receptors, Epoprostenol
-
Receptors, Prostaglandin
-
Receptors, Prostaglandin E
-
Epoprostenol
-
Adenylyl Cyclases
-
Alprostadil